CHA CDMO GLOBAL NETWORK: CHA Group’s Global CDMO Network is the ideal partner for commercializing
CGT (Cell and Gene Therapy) innovations globally

CHA Hospital GMP

Home to the world’s first in-hospital GMP facility for cell therapy production,
with a 20-year track record of excellence

Matica BioLabs

A leader in CDMO services, producing over 1,000 batches of cell therapies with specialized expertise in analytical development (AD) and process development (PD)

Matica Biotechnology

A global leader in cell and gene therapy development and production,
with a highly skilled CGT workforce based in the U.S.

Matica BioJapan

A key hub for immune cell therapy for cancer patients,
having administered over 10,000 treatments to date

Cell Gene Biobank

A large-scale, commercial CGT CDMO hub serving as an open innovation center
for collaborations across Asia

World-Class Pharmaceutical Production

Tailored Development Solutions

Delivering client-specific development platforms, featuring Korea’s pioneering cryopreservation technology, cutting-edge human tissue separation techniques, and cost-effective, high-efficiency mass cell cultivation processes

Custom Manufacturing Solutions

Offering fully customizable manufacturing platforms with independent production suites, including four standalone facilities
Designed for small, medium, and large-scale production, supported by Korea’s most extensive track record in stem cell manufacturing and state-of-the-art cell therapy production facilities

Comprehensive Clinical Trial Platforms

Providing bespoke clinical trial services through partnerships with domestic and global CROs, ensuring a seamless and integrated platform for managing clinical trials from start to finish

CDMO Inquiry

CHA Network

[Main Office] CHA Bio Complex, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488

Affiliates

Global Healthcare

Business

CHA Biotech

CDMO